SciELO - Scientific Electronic Library Online

 
vol.16 número28Cumplimiento de la normatividad en la publicidad de medicamentos de venta libre en ColombiaNiveles de citoquinas en suero de adictos a heroína bajo consumo activo o en terapia de mantenimiento con metadona y controles sanos en Pereira (Colombia) índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Investigaciones Andina

versión impresa ISSN 0124-8146

Resumen

MACHADO ALBA, Jorge Enrique; MORALES PLAZA, Cristhian David  y  HOYOS SOTO, Valentina. Frequency of risk potential drug interactions between antiretrovirals and other drugs in Colombian patients. Investig. andina [online]. 2014, vol.16, n.28, pp.910-920. ISSN 0124-8146.

Objectiv: determine the prevalence of potential risk drug interactions between antiretroviral and other drugs in Colombian patients with HIV/AIDS. Materials and methods: cross-sectional study who took the prescription drugs a population database of 6.2 million users from May 1 to July 31, 2012. To identify potential interactions, we sought dispensing antiretrovirals: Nucleoside Reverse Transcriptase Inhibitors, Non-Nucleoside Inhibitors of Reverse Transcriptase (NNRTIs), Protease Inhibitors (PIs), integrase inhibitors, CCR5 antagonists and fusion inhibitors with other risk drugs because their ineffectiveness or toxicity. Analysis by SPSS 21.0. Results: 968 patients were obtained, mostly men (n = 844, 87.2%), mean age 41.6±10.5 years (range: 3-75 years) and male:female ratio of 5.8:1, from 25 cities. In total we found 49 associations of risk; the IPs being involved in 40 cases. The most common interaction was between IPs and statins (OR: 29.5, 95%CI:14,837-58, 785, p <0.001), IPs and antidepressants (OR: 29.5, 95%CI:11,891-73, 266, p <0.001), and corticosteroids (OR: 15.5, 95%CI:4,938-49, 698, p<0.001) and between NNRTIs with warfarin (OR: 46.3, 95% CI :4,108-520, 764, p<0.001). Receive ritonavir became an potential risk factor interactions (OR: 6.7, 95% IC:3.562-12.934; p<0.001) between people living in the Manizales with other places (OR: 3.7, 95%IC:1.043-12.909; p=0.030). Conclusions: the potential interactions between antiretrovirals and other drug groups are common. It is imperative prior assessment and continuous monitoring patients undergoing risk. We recommend similar strategies to those of the current work to strengthen pharmacovigilance programs.

Palabras clave : Pharmacoepidemiology; Pharmacovigilance; Anti-Ret;roviral Agents; HIV Infections; Acquired Immunodeficiency Syndrome; Drug Interactions; Colombia.

        · resumen en Español | Portugués     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons